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Increasing evidence indicates that the capacity to induce protective Th1 immune responses is impaired in
early childhood, an observation that can be partially attributed to deficiencies in antigen-presenting-cell
function. Synthesis of interleukin 12 (IL-12), a key Th1-trophic cytokine, is markedly reduced in the neonatal
period, though there is a paucity of knowledge concerning the ontogeny of IL-12-synthetic capacity throughout
the childhood years. Hence, we examined the production of bioactive IL-12 p70 by circulating mononuclear
cells in a population of healthy individuals. As expected, the capacity to synthesize IL-12 p70 in response to
either lipopolysaccharide or heat-killed Staphylococcus aureus was markedly impaired at birth, even after
priming of cells with gamma interferon. Surprisingly however, IL-12 p70 synthesis by peripheral blood
mononuclear cells from both 5- and 12-year-old children was still substantially below that seen in adults, and
this did not appear to be related to excessive production of IL-10. In contrast, dendritic cells from adults and
neonates, derived from monocytes with granulocyte-macrophage colony-stimulating factor and IL-4, synthe-
sized equivalent amounts of IL-12 p70 in response to microbial stimulation. This indicates that the impaired
capacity for IL-12 synthesis in childhood is not an intrinsic property of circulating mononuclear cells but
rather can be readily overcome in response to appropriate maturational stimuli. Because IL-12 arose pre-
dominantly from circulating HLA-DR cells that lacked B-cell- and monocyte-specific markers, we propose
that the slow maturation of IL-12-synthetic capacity in the childhood years can be attributed to deficiencies in
the number and/or function of dendritic cells.
It is acknowledged that early childhood is characterized by
an increased susceptibility to infectious diseases, and this has
been attributed both to immaturity of the immune system at
birth and to the sluggish development of immune competence
in the postnatal and early childhood years. This vulnerability to
infections appears to be particularly pronounced in relation to
intracellular pathogens, reflecting functional immaturity of
cell-mediated immunity. However, considerable gaps still exist
in current understanding of the mechanisms underlying im-
mune maturation in healthy children.
While intrinsic properties of T cells undoubtedly contribute
to the immunological immaturity observed in the neonatal
period (1, 3, 16, 17, 25), it is also clear that many of the
“deficiencies” observed in neonatal immune function are de-
pendent on antigen-presenting cells (APCs) (28, 35). Neonatal
T cells proliferate relatively poorly when stimulated with
freshly isolated allogeneic neonatal dendritic cells (DC) but
proliferate as strongly as adult T cells when stimulated with
adult DC (18, 24). Similarly, the reduced capacity of neonatal
T cells to produce the key T helper type 1 (Th1) cytokine
gamma interferon (IFN-) is markedly improved when these T
cells are cultured with adult, rather than cord, APCs (10, 34,
35), suggesting that neonatal APCs lack the capacity to deliver
important Th1 polarizing signals to T cells.
A number of investigators have therefore examined the ca-
pacity of cord blood cells to synthesize interleukin 12 (IL-12),
a key Th1-trophic cytokine. While reports suggest that neona-
tal and adult peripheral blood mononuclear cells (PBMC) syn-
thesize equivalent amounts of IL-12 p40 in response to micro-
bial stimuli (32), secretion of bioactive IL-12 p70 by cord blood
cells is generally thought to defective (19, 20), perhaps as a
consequence of decreased p40 mRNA stability (20). Further-
more, it appears that neonatal monocyte-derived DC also have
a specific defect in IL-12 p35 gene expression, though this can
be corrected by the addition of exogenous IFN- to cultures
(15). The exact nature of the signals required to induce neo-
natal cells to synthesize adult levels of bioactive IL-12 remains
poorly understood at present.
There is also a paucity of knowledge concerning the rate at
which IL-12 production develops between infancy and adult-
hood, an issue with fundamental implications for our under-
standing of host defense and immunoregulation during child-
hood. We approached this issue by examining the ontogeny of
IL-12 production at various ages between infancy and adult-
hood. In a cross-sectional study, PBMC were obtained from
cord blood, 5-year-old children, 12-year-olds, and adults and
were examined for their capacity to synthesize IL-12 p70 in
response to microbial stimuli.
MATERIALS AND METHODS
Culture medium and reagents. Except where indicated, cells were cultured in
RPMI 1640 (Gibco BRL) supplemented with L-glutamine, 10% fetal calf serum
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(Trace BioSciences, Sydney, Australia), 2-mercaptoethanol (4  105 M; Sig-
ma), and gentamicin (Pharmacia), referred to below as complete medium. The
following were purchased: recombinant human IFN- (Pharmingen), IL-4
(Pharmingen), Escherichia coli lipopolysaccharide (LPS) (serotype O55:B5; Sig-
ma), and heat-killed Staphylococcus aureus strain Cowan I (SAC; obtained from
Calbiochem under the brand name Pansorbin). Recombinant human granulo-
cyte-macrophage colony-stimulating factor (GM-CSF) was a gift from Glaxo,
Geneva, Switzerland.
Subjects. Heparinized cord blood was obtained from the placentas of normal
full-term deliveries following elective cesarean section at King Edward Memorial
Hospital, Perth, Australia. Recruitment for the study was from antenatal clinics
at the King Edward Hospital and from nearby private obstetric practices. Blood
samples from healthy 5- and 12-year-old children were obtained from subjects
taking part in a community-based, prospective birth cohort study of normal
pregnancy. Adult blood samples were from healthy laboratory volunteers. This
study was carried out with the approval of the Ethics Committee, Princess
Margaret and King Edward Memorial Hospitals, and the parents or guardians of
all children provided written consent.
Cell preparation and culture. Mononuclear cells (PBMC) were isolated by
density gradient centrifugation and cryopreserved in liquid nitrogen, as previ-
ously described (21). Previous studies from our laboratory and elsewhere have
demonstrated that this procedure does not distort cellular immune responses (4,
21). In particular, the capacities of both cord blood and adult PBMC to synthe-
size IL-12 are not influenced by cryopreservation (our unpublished data).
For functional studies, PBMC that had been cryopreserved were thawed and
resuspended at 106 viable cells/ml in complete medium. Cells were primed with
IFN- (10 ng/ml) for 3 h prior to addition of either LPS (1 to 100 ng/ml) or SAC
(0.01 to 0.05%). These concentrations were chosen based on preliminary dose-
response experiments. After culture at 37°C under 5% CO2 for 24 h, superna-
tants were collected and stored at 20°C for analysis of cytokine production by
enzyme-linked immunosorbent assay (ELISA). In preliminary experiments with
adult and cord blood PBMC, we determined that IL-12 p70 levels reached a
plateau at 24 h after stimulation and did not increase further at 48 h.
Generation of DC from peripheral blood. DC were generated from adult or
cord monocytes as described elsewhere (29), with minor modifications. In our
initial experiments, adherence proved to be an inefficient method for isolation of
monocytes from cord blood samples, because of inconsistent adherence and
contamination of samples with fetal nucleated erythrocytes. Depletion of fetal
erythrocytes by use of glycophorin A antibodies and immunomagnetic beads has
been described previously (13), so this was incorporated into a method for
monocyte isolation by negative selection. By using antibodies against CD2, CD7,
CD16, CD56, CD19, and glycophorin A, followed by anti-mouse immunomag-
netic beads (Dynal), a population containing 90% CD14 cells was obtained.
These monocytes were then cultured in complete medium supplemented with
GM-CSF (50 ng/ml) and IL-4 (20 ng/ml). Every 2 or 3 days, fresh medium,
GM-CSF, and IL-4 were added. After 7 days of culture, nonadherent cells
corresponding to the DC-enriched fraction were harvested, washed, and used for
subsequent experiments. This DC-enriched fraction contained 90% DC as
determined by morphology and flow cytometry (CD1a staining) and by the ability
of these cells to stimulate a vigorous allogeneic mixed leukocyte reaction.
Flow cytometric analysis. For immunophenotyping, cells were washed in phos-
phate-buffered saline supplemented with 0.1% sodium azide and 1% normal
human serum and were incubated for 30 min on ice with one of the following
monoclonal antibodies (MAbs) (all obtained from BD Pharmingen): fluorescein
isothiocyanate (FITC)-conjugated CD1a, FITC-conjugated CD14, phycoerythrin
(PE)-conjugated CD80, PE-conjugated CD86, and peridinnin chlorophyll protein-
conjugated HLA-DR. Cells were also similarly incubated with corresponding
isotype-matched control MAbs. Circulating DC were enumerated as “lineage-
negative,” HLA-DR cells by using a commercial kit containing FITC-conjugated
CD3, CD14, CD16, CD19, CD20, and CD56, PE-conjugated CD123, PerCP-
conjugated HLA-DR, and CD11c APC (BD Pharmingen). Analysis was per-
formed using a FACSCalibur flow cytometer (Becton Dickinson).
Detection of IL-12 and IL-10 by ELISA. Levels of IL-12 and IL-10 in culture
supernatant were determined by specific ELISAs. IL-12 p70 protein was mea-
sured by an in-house ELISA, using a rat anti-human IL-12 p70 MAb (clone
20C2; Pharmingen) for capture and biotinylated mouse anti-human IL-12 p40/
p70 (clone C8.6; Pharmingen) for detection. The standard curve was generated
using serial dilutions of recombinant IL-12 p70 (Hoffmann-La Roche); the limit
of detection was 15 pg/ml. IL-10 protein was measured as previously described
(31). The limit of detection was 4 pg/ml.
Statistical analysis. Data were expressed as means  standard errors (SE),
and the statistical significance of comparisons was assessed by either a paired or
an unpaired t test as appropriate.
RESULTS
Age-related changes in capacity to synthesize IL-12 p70. We
first examined the synthesis of bioactive IL-12 p70 by PBMC
obtained from healthy subjects of various ages, ranging from
neonates to adults. Following IFN- priming, LPS-stimulated
PBMC from adults released substantial amounts of IL-12 p70
(1,922  358 pg/ml), in accordance with previous reports (Fig.
1A). By contrast, and in line with our predictions, neonatal
PBMC that had been stimulated in the same manner released
very little IL-12 (64.1  22.9 pg/ml). What was most surprising
FIG. 1. Age-related changes in IL-12 p70 synthesis. PBMC were obtained from neonates (n  30), 5-year-old children (n  29), 12-year-olds
(n  55), and adults (n  12). After 24 h of stimulation, IL-12 p70 levels were determined by ELISA. Values are means  SE. (A) Cells were
primed with IFN- (10 ng/ml) for 3 h prior to addition of LPS (10 ng/ml). (B) Cells were primed with IFN- (10 ng/ml) for 3 h prior to addition
of heat-killed S. aureus (Pansorbin 0.05%). The statistical significance of comparisons between groups was assessed by an unpaired Student’s t test.











was the slowness with which IL-12-synthetic capacity devel-
oped during the intervening years. The levels of IL-12 synthe-
sized by PBMC from both 5-year-old children (311.9  58.4
pg/ml) and 12-year-olds (778.7  123.5 pg/ml) were still sub-
stantially below those seen in adults. The data shown were
obtained with an LPS concentration of 10 ng/ml; a similar
pattern of results was observed with LPS concentrations from
1 to 100 ng/ml (data not shown).
We next examined the ability of heat-killed SAC to activate
PBMC, in order to determine whether the reduced capacity to
synthesize IL-12 in childhood might be stimulus specific. As
with LPS, SAC also induced the synthesis of high levels of
IL-12 by adult PBMC, whereas PBMC from neonates and
children released significantly smaller amounts of IL-12 (Fig.
1B). The data shown in Fig. 1B were obtained with a SAC
concentration of 0.05%; a similar pattern of results was ob-
served with a concentration of 0.01% (data not shown). Given
that LPS and SAC activate cells via distinct Toll-like receptors
(TLR4 and TLR2, respectively), it thus appeared unlikely that
the reduced levels of IL-12 synthesis observed in the two pe-
diatric populations can be attributed to selective impairment of
signaling through either TLR2 or TLR4.
IL-12 p70 synthesis in children: effect of serum. Neonatal
leukocytes have also been shown to synthesize less tumor ne-
crosis factor alpha (TNF-) than adult cells in response to LPS
(8). However, this deficit in TNF- release can be partially
overcome by the addition of adult serum to neonatal cells
cultured in medium alone, suggesting that neonatal cells do
have an intrinsic capacity to respond to endotoxin, provided
that a key factor(s) in serum is present in culture. Accordingly,
we examined whether sera from various sources were also able
to augment IL-12 synthesis by PBMC from neonates and chil-
dren. Whereas addition of fetal calf serum (FCS) to RPMI
significantly boosted IL-12 p70 release by adult PBMC stimu-
lated with endotoxin, FCS had no such effect when added to
PBMC from neonates and children (Fig. 2). Similarly, addition
of normal adult AB serum to RPMI also enhanced IL-12 p70
release by adult PBMC but had no effect on IL-12 p70 release
by PBMC from the two pediatric populations (data not
shown). When adult and cord blood PBMC were cultured in
the defined serum-free medium AIM-V (Gibco), IL-12 p70
levels were greater than those observed with RPMI alone but
still well below those observed when PBMC were cultured in
RPMI supplemented with either FCS or normal adult AB
serum (data not shown). These findings suggest that the re-
duced capacity for IL-12 synthesis in childhood stems from a
reduced capacity of LPS-serum protein complexes to specifi-
cally activate IL-12 genes rather than from an inability to
respond to endotoxin per se.
Cellular source of IL-12. Because IL-12 can be produced by
a variety of circulating mononuclear cells, we sought to deter-
mine whether the absence of particular cell populations in cord
blood might explain the reduced capacity for IL-12 p70 syn-
thesis. Early reports suggested that IL-12 production by adult
PBMC could largely be attributed to major histocompatibility
complex (MHC) class II-positive cells, particularly B cells and
monocytes (9, 12). While efficient depletion of HLA-DR cells
from adult PBMC by using immunomagnetic beads inhibited
IL-12 production, depletion of the CD14, CD19, or CD56
populations from adult PBMC did not reduce IL-12 synthesis
in response to LPS and IFN- stimulation (Fig. 3). In some
subjects, depletion of CD14 cells actually increased IL-12
production, suggesting that monocytes might inhibit IL-12 pro-
duction under some circumstances. However, there was no
evidence that neonatal monocytes had a similar suppressive
effect on IL-12. Depletion of CD14 cells from cord blood
PBMC did not enhance IL-12 synthesis following LPS and
IFN- stimulation, thereby excluding a suppressive effect of
neonatal monocytes as an explanation for the reduced IL-12
FIG. 2. Effects of serum factors on IL-12 p70 synthesis. PBMC
were cultured in RPMI either alone or supplemented with 10% FCS
and were stimulated with IFN- (10 ng/ml) for 3 h prior to addition of
LPS (10 ng/ml). After 24 h, IL-12 p70 levels were determined by
ELISA. Values are means  SE for at least nine individuals from each
age group. The statistical significance of comparisons was assessed by
a paired t test.
FIG. 3. Cellular source of IL-12 p70. Monocytes, B cells, NK cells,
and class II MHC cells were depleted from adult PBMC, by using
immunomagnetic beads specific for CD14, CD19, CD56, or HLA-DR,
to less than 2% of the starting populations. Cells were primed with
IFN- (10 ng/ml) for 3 h prior to addition of LPS (10 ng/ml). After 24 h
of stimulation, IL-12 p70 levels were determined by ELISA, and the
results were compared to those for undepleted PBMC (n  5). Only
HLA-DR depletion led to a significant reduction in IL-12 p70 synthe-
sis.











synthesis. (Because of limitations in numbers of available cells,
it was not possible to conduct these experiments using cells
from 5-year-olds and 12-year-olds).
These experiments suggested, much as expected, that the
major sources of IL-12 in adult peripheral blood are HLA-
DR cells that lack CD14 and CD19 and are thus putative DC.
We thus enumerated DC (lineage negative, HLA-DR) in
adult and cord PBMC. Cord blood DC numbers (0.41% 
0.26% of PBMC) were reduced compared to adult blood DC
numbers (0.82%  0.24% of PBMC [data not shown]), as in a
recent report (33). However, this modest reduction in DC
numbers did not appear sufficient on its own to explain the
marked reduction in IL-12-synthetic capacity observed in cord
blood cells, suggesting that additional deficits in DC matura-
tion were responsible.
Relative production of IL-10 and IL-12 is altered in neo-
nates. We next examined IL-10 synthesis by PBMC from the
different age groups, given that this cytokine is an important
regulator of IL-12 production. Data shown in Fig. 4 are ex-
pressed as IL-10/IL-12 ratios. The response of cord blood
PBMC to LPS–IFN- stimulation was characterized by pro-
duction of significant amounts of IL-10 and little if any IL-12,
such that the IL-10/IL-12 ratios were nearly always2 (Fig. 4).
In contrast, the reverse was seen in 5-year-olds, 12-year-olds,
and adults, where IL-12 production was greater than IL-10
production and the IL-10/IL-12 ratios were nearly always 	2.
IL-12 synthesis by monocyte-derived DC. We next asked
whether the impaired capacity to synthesize IL-12 is an intrin-
sic property of circulating APCs in childhood, or whether these
cells can be induced to mature in response to cytokines. Ac-
cordingly, purified CD14 monocytes from adult and cord
blood were induced to undergo DC differentiation in vitro by
use of GM-CSF and IL-4 for 7 days. (Because of limitations in
numbers of available cells, it was not possible to conduct these
experiments using cells from 5-year-old children and 12-year-
olds). The yields of DC were similar in both adult and cord
blood experiments. Both monocyte-derived DC populations
expressed HLA-DR, CD80, and CD86 to similar extents and
displayed similar APC function, as determined by allogeneic
MLR using adult T cells as the responder population (data not
shown). Importantly, the two DC populations released equiv-
alent amounts of IL-12 p70 following stimulation with either
LPS alone or LPS plus IFN- (Fig. 5). Thus, it appears that the
reduced ability of neonatal mononuclear cells to synthesize
bioactive IL-12 can be overcome following short-term expo-
sure to maturation signals such as GM-CSF and IL-4.
DISCUSSION
Childhood clearly represents a critical period in the devel-
opment of immune responsiveness, with important implica-
tions for the development of both infectious and noninfectious
disorders. In order to gain insight into the mechanisms respon-
sible for impaired Th1 responses in childhood, we examined
the ontogeny of IL-12 in a population of healthy individuals.
The salient findings to emerge were that the capacity of PBMC
to synthesize bioactive IL-12 p70 was markedly impaired at
birth, that it matured surprisingly slowly during childhood, and
that adult levels of IL-12 p70 synthesis were not acquired until
after the age of 12 years. This pattern of reduced IL-12 pro-
duction was observed in response to stimulation with two mi-
crobial products that initiate IL-12 gene expression via distinct
mechanisms.
A variety of in vivo and in vitro studies have demonstrated
that Th1 lineage development is generally deficient in the early
postnatal period (5, 6, 27, 36), particularly the ability to de-
velop stable Th1 memory (1, 2). However, it is also clear that
strong neonatal Th1 responses can be elicited by the provision
of exogenous IL-12 (11, 37) or by the use of adult, rather than
neonatal, APCs (34, 35), suggesting that the maturity of APC
populations is a key rate-limiting step in the postnatal devel-
opment of Th1 function. This notion is supported by the find-
ing that antigen challenge in the context of potent adjuvants
that are known to up-regulate APC function allows neonatal
animals to mount mature Th1 responses (14, 23, 26). Similarly,
variations in the immune responses that follow neonatal im-
munization in humans are likely to be secondary to the differ-
ing adjuvant properties of particular vaccine antigens and their
FIG. 4. Age-related changes in synthesis of IL-10 and IL-12.
PBMC from neonates, 5-year-old children, and adults were stimulated
with LPS plus IFN-. After 24 h, IL-10 and IL-12 p70 concentrations
were determined by ELISA. Data are shown as ratios of IL-10 to
IL-12.
FIG. 5. Monocyte-derived DC from neonates and adults have sim-
ilar capacities to synthesize IL-12 p70. DC were generated from adult
or neonatal CD14 monocytes, by using GM-CSF and IL-4, as de-
scribed in Materials and Methods and were primed with IFN- (10
ng/ml) for 3 h prior to addition of LPS (10 ng/ml). After 24 h, IL-12
p70 levels were determined by ELISA. Data are shown as means SE.











effects on accessory cell populations. Whereas mycobacterial
vaccines with intrinsic adjuvant properties can induce vigorous
IFN- responses in many human infants (22), it is clear that
antigen-specific responses to diphtheria, tetanus, and pertussis
vaccination in infancy are Th2 skewed (31). It therefore ap-
pears that the functional deficiencies of neonatal APCs are not
intrinsic to these cells, as they can be induced to mature to
adult-equivalent functional competence via the provision of
appropriate microenvironmental signals. As shown in Fig. 5,
the relative inability of neonatal cells to synthesize IL-12 p70
can be readily overcome by the provision of cytokine signals
that induce DC differentiation in vitro. Whereas the develop-
ment of maximal IL-12-synthetic capacity takes many years in
vivo, this can be compressed into just a few days in vitro by
using cytokines such as GM-CSF and IL-4.
Previous studies of in vitro IL-12 production in the neonatal
period have yielded somewhat conflicting results, though this
can be partially explained by the fact that some investigators
have measured IL-12 p40 rather than the bioactive p70 het-
erodimer. Those investigators who have focused on IL-12 p70
synthesis have generally concluded that production of the bio-
active heterodimer in the neonatal period is reduced following
short-term culture (19, 20).
The mechanisms underlying the reduced capacity of neona-
tal cells to produce bioactive IL-12 are multiple. Lee et al.
showed reduced stability of p40 transcripts in cord blood
PBMC (20), whereas Goriely et al. demonstrated that neonatal
monocyte-derived DC display a marked inhibition of IL-12 p35
gene expression compared to adult DC (15). Importantly, ad-
dition of IFN- to neonatal DC restored both p35 and IL-12
p70 synthesis to adult levels (15). While our findings with
respect to neonatal monocyte derived DC are very similar (Fig.
5), it is also clear that circulating cord mononuclear cells pro-
duce very little IL-12 p70, even in the presence of IFN- (Fig.
1), and that IFN- responsiveness develops only during cyto-
kine-driven differentiation of monocytes to DC. Given that
cord blood APC populations appear to express the IFN-
receptor (39), we suspect that this lack of IFN- responsiveness
exhibited by cord blood PBMC reflects changes in intracellular
signaling in response to IFN-. While it is possible that the
reduced synthesis of IL-12 p70 observed in neonates can be
partly attributed to concomitant IL-10 production and result-
ing high IL-10/IL-12 ratios (Fig. 4), this does not appear to be
a satisfactory explanation for the relatively slow development
of IL-12-synthetic capacity observed in later childhood and
adolescence (Fig. 4).
While IL-12 can be produced by a variety of circulating
mononuclear cells, including DC, monocytes, B cells, and NK
cells, our depletion experiments and the work of others suggest
that the major source of IL-12 in adult peripheral blood is
HLA-DR cells that lack CD14, CD19, and CD56 and are thus
putative DC. However, it appears that the modest reduction in
cord blood HLA-DR, lineage-negative cell numbers reported
by others (33), and confirmed in our present study, is insuffi-
cient on its own to explain the marked reduction in IL-12-
synthetic capacity observed in cord blood cells. Neonatal DC
appear immature compared to their adult counterparts, with
reduced expression of key surface molecules and reduced ca-
pacity for antigen presentation (18, 33). Therefore, the imma-
turity of cord blood DC appears to be the most likely expla-
nation for reduced IL-12 p70 production by cord PBMC,
though this will be need to be confirmed in future studies of
highly purified cord blood DC.
The capacity to synthesize adult levels of IL-12 does not
appear to develop until well into adolescence, and the factors
that regulate the ontogeny of IL-12 remain poorly defined.
Variations in the rate at which individuals develop the capacity
to synthesize IL-12 are almost certainly determined both by
variations in the IL-12 genes themselves and by variations in
the pattern of exposure to microbial stimuli during childhood.
Other than cord blood studies, there have been no studies to
our knowledge of IL-12 production by healthy children in the
postnatal period. Bont et al. recently examined IL-12 release
by PBMC from young infants with severe respiratory syncytial
virus (RSV) infection (7). IL-12 production was generally
lower than 100 pg/ml following LPS-plus-IFN- stimulation,
though it was not clear whether the levels of IL-12 produced
were influenced by the RSV infection, as the experiments were
not repeated when the children had recovered from the infec-
tion. There is clearly a need, therefore, for longitudinal studies
of IL-12 in children that examine the effects of defined infec-
tions or vaccinations and IL-12 polymorphisms on the produc-
tion of this important cytokine, and also for studies of the
relationship between the kinetics of postnatal development of
IL-12 and the capacity to respond to vaccine or infectious
challenge.
In this context, we have recently examined IFN- ontogeny
in a cohort of children and found evidence of an inverse rela-
tionship between susceptibility to RSV infection and the ki-
netics of postnatal development of the capacity of PBMC to
secrete IFN- (30). Of further interest, we demonstrated that
for children immunized at 2, 4, and 6 months of age, in vitro
IFN- responses to tetanus toxoid varied markedly in stability
over the ensuing year, with vaccine-specific IFN- reactivity
being lost in a substantial subset (30). Such instability of Th1
function in the early postnatal period is similar to that reported
for the mouse (1). Significantly, it is becoming clear that IL-12
is not only required during the initial phases of Th1 polariza-
tion but is also required to maintain the efficiency of the IFN-
transcription machinery in Th1 effector cells (38). Because Th1
memory cells lose their capacity to produce IFN- in the ab-
sence of sufficient IL-12 (38), we speculate that the low and
variable levels of IL-12 production demonstrated here may
provide an explanation for our earlier findings on the instabil-
ity of vaccine-specific Th1 memory in infants (30). Future stud-
ies will address this very important issue.
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